Table 2.

Recommendations for Patient and Community-Centered Interventions to Address Cardio-Oncologic Health Disparities

•Develop and validate measurement tools for specific SDOH domains salient to under-represented populations with CVD secondary to cancer therapeutics. Moreover, SDOH measurement tools should be linked with electronic medical records to identify patient and community-tailored targets for intervention.

•Funding priorities should target the use of SDOH measures in multimethod research (qualitative/quantitative [mixed methods] and community-based participatory research) to highlight the voices of under-represented populations when creating community data for social risk stratification in the cardio-oncology populations.

•Clinical researchers should leverage existent data from longitudinal cohort studies to investigate the intersectional impact of adverse SDOH on comorbid CVD and cancer health disparities to identify intervention targets along the signaling pathways linking SDOH to outcomes disparities.

•Interdisciplinary care training should be grounded in SDOH to educate clinical teams as change agents and health equity advocates throughout the care transition continuum for cardio-oncology patients and their families.

•Policy interventions must target sustainable community-informed social resources and services that empower patients in the setting of comorbid CVD and cancer.

Abbreviations as in Table 1.